Home › Funds › CIBC Bancorp USA Inc. › AZN
CIBC Bancorp USA Inc. position in AZN
ASTRAZENECA PLC · Health Care
CIBC Bancorp USA Inc. reported holding 3,541,605 shares of AZN (ASTRAZENECA PLC) in its Q3 2026 13F filing — a position valued at US$544.6M, representing 0.78% of its reported portfolio and ranking #20 among its reported holdings. CIBC Bancorp USA Inc. has disclosed AZN holdings in 4 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How CIBC Bancorp USA Inc.'s AZN position evolved
CIBC Bancorp USA Inc. first disclosed a stake in AZN in Q3 2025 at 21,508 shares (US$1.7M). The position peaked in Q1 2026 at 4,595,892 shares, worth US$869.5M. Across 4 filings, CIBC Bancorp USA Inc. increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,541,605 shares valued at US$544.6M — a reduction of -231,392 shares quarter over quarter.. Notable position changes include a 21268% increase in Q1 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 21.51K | $1.65M | New |
| Q1 2026 | 4.60M | $869.50M | Add |
| Q2 2026 | 3.77M | $680.75M | Reduce |
| Q3 2026 | 3.54M | $544.60M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AZN and 13F data
AZN (ASTRAZENECA PLC) is a Health Care company. 64 other funds we track also report a position in AZN — the largest reported positions include INVESTOR AB (US$9.78B), Norges Bank Investment Management (US$6.33B), Capital World Investors (US$5.63B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AZN
- INVESTOR AB 51.59M sh · $9.78B · Q2 2026
- Norges Bank Investment Management 33.86M sh · $6.33B · Q2 2026
- Capital World Investors 30.08M sh · $5.63B · Q2 2026
- Wellington Management Group 28.54M sh · $5.36B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 28.54M sh · $5.36B · Q2 2026
- Capital World Investors 31.09M sh · $5.06B · Q3 2026
- Legal & General Investment Management America 25.75M sh · $4.82B · Q2 2026
- Franklin Resources 19.05M sh · $3.59B · Q3 2026
- VANGUARD ASSET MANAGEMENT, Ltd 19.12M sh · $3.09B · Q3 2026
- PRIMECAP MANAGEMENT CO/CA/ 18.11M sh · $2.92B · Q3 2026
- Amundi US 17.12M sh · $2.76B · Q3 2026
- Capital International Investors 15.89M sh · $2.59B · Q3 2026
More on CIBC Bancorp USA Inc.
FAQ
How long has CIBC Bancorp USA Inc. held AZN?
CIBC Bancorp USA Inc. has disclosed AZN holdings in 4 of the last 5 reported quarters, going back to Q3 2025.
What is CIBC Bancorp USA Inc.'s current position in AZN?
As of Q3 2026, CIBC Bancorp USA Inc. holds 3.54M shares of AZN (ASTRAZENECA PLC), valued at $544.60M, representing 0.78% of its reported portfolio and ranking #20.
Has CIBC Bancorp USA Inc. been buying or selling AZN?
In the latest 13F filing (Q3 2026), CIBC Bancorp USA Inc. reduced its position in AZN. The position peaked in Q1 2026 at 4.60M shares.
Which other funds hold AZN?
Other major institutional holders of AZN include INVESTOR AB, Norges Bank Investment Management, Capital World Investors, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.